ARANESP (Amgen Inc)
Welcome to the PulseAid listing for the ARANESP drug offered from Amgen Inc. This Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amgen Inc |
| NON-PROPRIETARY NAME: | darbepoetin alfa |
| SUBSTANCE NAME: | DARBEPOETIN ALFA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2006-09-11 |
| END MARKETING DATE: | 0000-00-00 |
ARANESP HUMAN PRESCRIPTION DRUG Details:
| Item Description | ARANESP from Amgen Inc |
| LABELER NAME: | Amgen Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(ug/mL) |
| START MARKETING DATE: | 2006-09-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55513-002_866e3559-ccea-4dab-967e-6dfca4768ea9 |
| PRODUCT NDC: | 55513-002 |
| APPLICATION NUMBER: | BLA103951 |
Other DARBEPOETIN ALFA Pharmaceutical Manufacturers / Labelers:
